I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD8-positive, alpha-beta T cell | 9 studies | 19% ± 4% | |
| natural killer cell | 9 studies | 20% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 21% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 19% ± 2% | |
| CD4-positive, alpha-beta T cell | 7 studies | 19% ± 2% | |
| plasmacytoid dendritic cell | 7 studies | 24% ± 7% | |
| B cell | 6 studies | 21% ± 3% | |
| regulatory T cell | 6 studies | 18% ± 3% | |
| epithelial cell | 4 studies | 39% ± 14% | |
| endothelial cell | 4 studies | 21% ± 7% | |
| ciliated cell | 4 studies | 29% ± 8% | |
| CD4-positive, alpha-beta memory T cell | 4 studies | 19% ± 4% | |
| gamma-delta T cell | 4 studies | 24% ± 14% | |
| classical monocyte | 3 studies | 30% ± 6% | |
| conventional dendritic cell | 3 studies | 32% ± 11% | |
| exhausted T cell | 3 studies | 23% ± 4% | |
| mature NK T cell | 3 studies | 17% ± 1% | |
| non-classical monocyte | 3 studies | 33% ± 5% | |
| placental villous trophoblast | 3 studies | 23% ± 4% | |
| precursor B cell | 3 studies | 20% ± 0% | |
| fibroblast | 3 studies | 21% ± 5% | |
| GABAergic neuron | 3 studies | 23% ± 5% | |
| dendritic cell | 3 studies | 35% ± 16% | |
| neuron | 3 studies | 26% ± 12% |
